Nov 8 (Reuters) - ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS REPORTS RECORD THIRD QUARTER 2023
FINANCIAL
RESULTS AND RAISES FULL-YEAR 2023 GUIDANCE
* ANI PHARMACEUTICALS INC: COMPANY RAISES GUIDANCE: NET
REVENUE TO
$468 MILLION TO $478 MILLION FOR FULL YEAR 2023
* ANI PHARMACEUTICALS INC: CASH AND CASH EQUIVALENTS WERE
$193.1
MILLION WITH YEAR-TO-DATE (NINE MONTH) CASH FLOW FROM OPERATIONS
OF $74.2 MILLION
* ANI PHARMACEUTICALS INC- SEES FY ADJUSTED NON-GAAP DILUTED
EPS
$4.29 - $4.57
Source text for Eikon: ID:nGNXbtTpnm
Further company coverage: ANIP.O
((Reuters.Briefs@thomsonreuters.com;))